Article info

Download PDFPDF

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Authors

  1. Correspondence to Professor Robert BM Landewé, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands; landewe{at}rlandewe.nl
View Full Text

Citation

Landewé RB, van der Heijde D, Dougados M, et al
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Publication history

  • Received December 16, 2019
  • Revised April 9, 2020
  • Accepted April 13, 2020
  • First published May 7, 2020.
Online issue publication 
June 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.